CIK: 1556270 - Address: C/O Dentsply Sirona Inc, 13320 Ballantyne Corporate Place, Charlotte, NC 28277
52 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/22/24 17:02
2/21/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d100206.9400182D
2/16/24 17:56
2/14/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0004582D
2/9/24 17:00
2/7/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d81467.850121879D
2/9/24 17:00
2/7/24
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-6,871572.610-12-1379D
12/6/23 17:01
12/4/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,06879.540132079D
12/6/23 17:01
12/4/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-3,657513.050-7-879D
9/5/23 17:01
8/31/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,06879.540132373D
9/5/23 17:01
8/31/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-6,873512.010-13-1673D
8/8/23 17:59
8/5/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000173D
5/5/23 18:00
5/4/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d100178.2601173D
2/16/23 18:52
2/14/23
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0004573D
11/16/22 17:00
11/14/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,17862.000193771D
11/16/22 17:00
11/14/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-4,562434.470-11-1371D
11/9/22 17:00
11/7/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,24852.000246362D
11/9/22 17:00
11/7/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-5,060382.490-13-1862D
8/8/22 17:00
8/5/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000152D
5/23/22 17:00
5/20/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d100141.6001151D
2/16/22 19:24
2/14/22
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0003651D
8/17/21 17:02
8/13/21
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.m-4,051675.210-6-1149D
8/9/21 17:01
8/5/21
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000155D
2/24/21 17:01
2/22/21
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d10067.8501356D
2/19/21 17:00
2/17/21
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d1,30052.000258654D
2/19/21 17:00
2/17/21
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-7,450537.210-14-2054D
2/17/21 19:31
2/14/21
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0003843D
11/9/20 17:01
11/5/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-2,443469.320-5-1141D
11/9/20 17:01
11/6/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d20069.6803741D
8/7/20 19:12
8/5/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0000144D
2/19/20 21:31
2/14/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d00.0003644D
2/7/20 17:00
2/5/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d63445.840144843D
2/7/20 17:00
2/5/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOS.d-2,223277.840-8-1643D
1/16/20 18:00
1/15/20
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky Jonathan JayMEDOP,CEOM.d10045.8402637D
8/9/19 17:04
8/8/19
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOInterim M.d53647.200114935D
8/7/19 18:32
8/5/19
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOInterim M.d45845.840107523D
8/7/19 18:32
8/5/19
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOInterim S.d-2,584258.400-10-3023D
2/19/19 18:06
2/14/19
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00031223D
12/7/18 17:04
12/5/18
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.0001521D
2/16/18 20:01
2/14/18
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00031421D
12/7/17 17:33
12/5/17
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.0001519D
9/6/17 18:05
9/1/17
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00021518D
2/16/17 19:21
2/14/17
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.003321417D82982830221900017
12/7/16 16:15
12/5/16
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00331716D566530142-4112027
11/21/16 19:33
11/18/16
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d10547.533321715D5668325-186311020
9/2/16 18:00
9/1/16
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.003322313D79554828202210-4-1029
2/17/16 17:47
2/14/16
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.003311511D12-13-113-26-20-1042458101
12/8/15 18:09
12/5/15
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.003311110D35-69-6-830-2-1-10122866
9/3/15 16:07
9/1/15
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00332359D5615-8109-630-134-1555
2/18/15 18:32
2/14/15
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00330154D70262327-50-100-3-140-9
12/29/14 15:43
12/23/14
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d9595.06331423D61411126-30401-295-150
12/9/14 12:47
12/5/14
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00330262D594213187-1-1-11-121-12-6
9/3/14 16:06
9/1/14
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.003311462D3032-2-4-6-2100-1-5172512
2/19/14 17:11
2/14/14
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.00330341D4438311819117210-12225
9/4/13 09:33
9/1/13
IDXXIdexx Laboratories Inc /deDEHealthDiagnIn Vitro & In Vivo DiagnosticMazelsky JayMEOEVPM.d00.003311D16-2011-3-4-4-22410133536

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact